clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
HTAN Members Deliver Wealth of Tumor Biology Insights
News & Features
How p53 Loss Drives Cancer Risk in Ulcerative Colitis
News & Features
Mechanisms Behind Myocarditis in Cancer Patients Treated with Immune Checkpoint Inhibitors…
News & Features
Case Study Suggests Some Men with Advanced Prostate Cancer Could Benefit…
News & Features
Quitting Smoking after Cancer: The Sooner the Better for Improved Survival
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Where Are the Cell Therapies for Type 1 Diabetes?
Vertex Pharmaceuticals
News & Features
Where Are the Cell Therapies for Type 1 Diabetes?
Jonathan D. Grinstein, PhD
August 12, 2024
0
News & Features
Vertex and Orum Launch $945M+ Collaboration to Replace Chemotherapy with DAC
July 17, 2024
0
News & Features
Islet Cell Therapy Breaks Through: Three Patients Become Insulin Independent in Vertex Type 1 Diabetes Trial
June 25, 2024
0
News & Features
CASGEVY Is Durable in over 100 Patients, Editas’ Reni-cel Shows Clinical Promise
June 17, 2024
0
News & Features
Next-Generation Non-Opioid Pain Relievers Advance
February 15, 2024
0
News & Features
In Another Win for CRISPR, FDA Approves Casgevy for Beta Thalassemia
January 17, 2024
0
News & Features
Newcomer Tome Acquires Replace TX in $250M Gene Editing Deal
January 3, 2024
0
News & Features
Two Gene Therapies for Sickle Cell Disease Get FDA Nod, Including First Ever CRISPR-Based Therapy
December 11, 2023
0
News & Features
U.K. Approves Vertex/CRISPR Tx’s Casgevy for Sickle Cell and Beta Thalassemia
November 16, 2023
0
News & Features
Vertex Publishes on Its Promising Non-Opioid Pain Reliever
August 7, 2023
0
1
2
Page 1 of 2
Related Content
The End of the Beginning for Cell and Gene Therapy, Part 2
Study Links COVID-19 Pandemic to Increased Risk of Dyslipidemia in Adults
Sugar Restriction in Early Life Significantly Lowers Chronic Disease Risk, WWII Diet Study Shows
Behind the Breakthroughs: How to Turn $1,000,000 CAR Ts into “Real” Medicines
Inside Precision Medicine